4//SEC Filing
CONOR MEDSYSTEMS INC 4
Accession 0001181431-04-060233
CIK 0001108271operating
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 6:23 PM ET
Size
20.1 KB
Accession
0001181431-04-060233
Insider Transaction Report
Form 4
Gentile Frank T
Director
Transactions
- Conversion
Common Stock
2004-12-17+618,799→ 618,799 total(indirect: Held by H&Q Life Sciences Investors) - Conversion
Series D Preferred Stock
2004-12-17−559,999→ 0 total(indirect: Held by H&Q LIfe Sciences Investors)From: 2004-12-17→ Common Stock (559,999 underlying) - Conversion
Series E Preferred Stock
2004-12-17−109,200→ 0 total(indirect: Held by H&Q Healthcare Investors)From: 2004-12-17→ Common Stock (109,200 underlying) - Conversion
Series D Preferred Stock
2004-12-17−840,000→ 0 total(indirect: Held by H&Q Healthcare Investors)From: 2004-12-17→ Common Stock (840,000 underlying) - Conversion
Common Stock
2004-12-17+949,200→ 949,200 total(indirect: Held by H&Q Healthcare Investors) - Conversion
Series E Preferred Stock
2004-12-17−58,800→ 0 total(indirect: Held by H&Q LIfe Sciences Investors)From: 2004-12-17→ Common Stock (58,800 underlying)
Footnotes (3)
- [F1]The Issuer's Preferred Stock automatically converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering.
- [F2]The shares are held by H&Q Healthcare Investors. Hambrecht and Quist Capital Management, LLC is the Advisor of H&Q Healthcare Investors. The Reporting Person is Vice President, Research, of Hambrecht and Quist Capital Management, LLC
- [F3]The shares are held by H&Q Life Science Investors. Hambrecht and Quist Capital Management, LLC is the Advisor of H&Q Life Science Investors. The Reporting Person is Vice President, Research, of Hambrecht and Quist Capital Management, LLC
Issuer
CONOR MEDSYSTEMS INC
CIK 0001108271
Entity typeoperating
Related Parties
1- filerCIK 0001108271
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 6:23 PM ET
- Size
- 20.1 KB